Nordic Brain Tech AS (NBT) is a spin-off company (SME) from The Norwegian University of Science and Technology and St.Olavs Hospital. The company was founded in 2019 to commercialize a research-based intervention for treating migraines using remote biofeedback. Our goal is to improve brain health, and our ambitions include treating migraines and other neurological diseases by the use of technology. CEREBRI is our revolutionizing solution for prophylactic migraine treatment that takes advantage of mHealth developments to bring easier and cost-effective biofeedback therapies to patients.
The breakthrough innovation of CEREBRI will disrupt in the migraine treatment market by offering the following benefits to target users: 1) Patients will increase their control over their illness by reducing migraine episodes (30-50% less) as well as decreasing the need of medical treatment and associated side-effects, 2) Physicians will gain better knowledge of their patients and enable them to make accurate treatments and medication usage, and 3) Healthcare systems are offered a telemedicine tool for remote treatment and follow-up, leading to significant economic savings in physical consultations up and unnecessary treatments (potential annual costs savings of €11.3billion annually).
We estimate a total budget to execute the project that will reach €1.8M to cover the optimization of the device, the establishment of the manufacturing set-up, the realization of the clinical trials and CE-mark certification. At the end of the project CEREBRI will be ready for market entry.